{"id":"W2147154643","doi":"10.1517/14712598.7.11.1723","title":"L-BLP25: a MUC1-targeted peptide vaccine therapy in prostate cancer","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research; University of Alberta","funders":"","keywords":"Prostate cancer; Medicine; MUC1; Cancer vaccine; Antigen; Cancer; Peptide vaccine; Oncology; Prostate-specific antigen; Immunotherapy; Cancer research; Immunology; Internal medicine; Epitope","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005930637,0.0008682313,0.001143158,0.001137652,0.0002037861,0.0006163222,0.0009316538,0.001449957,0.002732981],"category_scores_gemma":[0.0003222018,0.0002228003,0.0004027028,0.001168714,0.0003945073,0.001145734,0.0003878821,0.001605223,0.003193658],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006926645,"about_ca_system_score_gemma":0.0006519908,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006349355,"about_ca_topic_score_gemma":0.001270558,"domain_scores_codex":[0.9998589,0.00002680586,0.00001101267,0.00002267407,0.00006314991,0.00001749333],"domain_scores_gemma":[0.9998944,0.00003080418,0.00001726252,0.000003497774,0.00003355118,0.0000204954],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001798954,0.000159978,0.00009611573,0.005387816,0.00005840192,0.0003847757,0.00003299973,0.0005863548,0.007004416,0.002011752,0.04811341,0.9359841],"study_design_scores_gemma":[0.000102559,0.0002680346,0.0007021473,0.001028246,0.00005343069,0.002052484,0.00003205396,0.0002334527,0.001457808,0.001516031,0.9925355,0.00001836212],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004753322,0.9956216,0.0004613213,0.0008671009,0.000720416,0.00001549705,0.0000195624,0.00002082101,0.001798351],"genre_scores_gemma":[0.00164823,0.9938611,0.0006162745,0.000838695,0.0004693003,0.00002457296,0.00006305615,0.000003224553,0.002475613],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002732981,"threshold_uncertainty_score":0.009142756,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.124768217387936,"score_gpt":0.3993203044805466,"score_spread":0.2745520870926105,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}